Has Virgil Dibiase received payments from drug or device companies?

Yes. Drug and device makers reported $3,955 in general payments to Virgil Dibiase across 264 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Virgil Dibiase did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Virgil Dibiase come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Virgil Dibiase

Neurology · South Bend, INNPI 1821024043

Payments from drug & device makers

$3,955in general payments, 2019–2025

Across 264 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
UCB, Inc.$366
Biohaven Pharmaceutical Holding Company Ltd.$249
Sanofi$208
Teva Pharmaceuticals USA, Inc.$150
EMD Serono, Inc.$129
plus $2K from 37 others

What the payments were for

Speaking & faculty fees$642%
Food & beverage$3,89198%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	70	$1,063
UCB, Inc.	19	$366
Biohaven Pharmaceutical Holding Company Ltd.	29	$249
Sanofi	11	$208
Teva Pharmaceuticals USA, Inc.	13	$150
EMD Serono, Inc.	9	$129
Biohaven Pharmaceuticals, Inc.	13	$126
Lilly USA, LLC	9	$124
Upsher-smith Laboratories LLC	6	$102
Supernus Pharmaceuticals, Inc.	5	$95
MDD US Operations, LLC	5	$88
Acorda Therapeutics, Inc	6	$77
Novartis	6	$77
AstraZeneca	4	$77
Johnson & Johnson	3	$72
Acadia Pharmaceuticals Inc	5	$70
Amgen	4	$65
Amneal Pharmaceuticals LLC	4	$58
Biogen	3	$50
Jazz Pharmaceuticals Inc.	3	$49
Pfizer	3	$48
Sunovion Pharmaceuticals Inc.	2	$47
Bausch Health US, LLC	2	$46
Neurocrine Biosciences, Inc.	2	$43
Argenx US, Inc.	2	$41
Genentech USA, Inc.	2	$37
Currax Pharmaceuticals LLC	2	$33
Livanova USA, Inc.	2	$33
Tanabe Pharma America, Inc.	2	$32
Adamas Pharmaceuticals, Inc.	2	$31
Vertical Pharmaceuticals, LLC	2	$30
Lundbeck LLC	1	$30
Catalyst Pharmaceuticals, Inc.	1	$27
Abbott	2	$24
Kyowa Kirin, Inc.	1	$24
OWP Pharmaceuticals, Inc.	2	$23
Eisai Inc.	1	$23
Takeda Pharmaceuticals U.S.A., Inc.	1	$16
Greenwich Biosciences, Inc.	1	$15
Avanir Pharmaceuticals, Inc.	1	$15
Assertio Therapeutics, Inc.	1	$15
SK Life Science, Inc.	1	$15
Arbor Pharmaceuticals, Inc.	1	$12

How this compares

$3,955 in reported general payments places this provider in the 55th percentile of 308 neurology providers in Indiana.

See all neurology providers in Indiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Carbidopa-LevodopaCarbidopa/Levodopa	17	$143

Paid to pharmacies, not to this prescriber.

Other neurology in South Bend

Kristi GeorgeIndianapolis$10.8M
Craig HerrmanIndianapolis$7.8M
Martin FarlowIndianapolis$4.8M
Jared BroschIndianapolis$4.7M
Ajay GuptaFort Wayne$2.5M
Christopher WilsonAvon$2M
Alexandru BarboiIndianapolis$1.9M
William ConteMerrillville$1.7M
James StevensFort Wayne$1.5M
Kathryn NevelIndianapolis$1M

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →